Magnesium sulphate for prevention of eclampsia: Are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 7, 2013, Pages 894-900

  Salinger, D H ^a,b   Mundle, S ^c   Regi, A ^d   Bracken, H ^e   Winikoff, B ^e   Vicini, P ^a,f   Easterling, T ^g  

^a University of Washington   (United States)

^b AMGEN INC   (United States)

^c GOVERNMENT MEDICAL COLLEGE   (India)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e GYNUITY HEALTH PROJECTS   (United States)

^f PFIZER INC   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Magnesium sulphate; pharmacokinetics; pre eclampsia

Indexed keywords

MAGNESIUM SULFATE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; ECLAMPSIA; EXPECTATION; FEMALE; HUMAN; HYPERTENSION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

ADOLESCENT; ADULT; ANTICONVULSANTS; BIOLOGICAL AVAILABILITY; DRUG ADMINISTRATION SCHEDULE; ECLAMPSIA; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MAGNESIUM SULFATE; METABOLIC CLEARANCE RATE; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 84877775080     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12222     Document Type: Article

References (16)

1. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63.
2. The Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877-90.
3. Belfort MA, Anthony J, Saade GR, Allen JC,. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304-11.
4. Sibai BM,. Hypertension. In:, Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics Normal and Problem Pregnancies, 4th edn. New York: Churchill Livingston; 2002. pp. 969.
5. Redman C,. Hypertension in pregnancy. In:, de Swiet SM, editor. Medical Disorders in Obstetric Practice, 2nd edn. Oxford: Blackwell Scientific Publications; 1989. pp. 278.
6. Dildy GA, Phelan JP, Cotton DB,. Complications of Pregnancy-Induced Hypertension. In:, Clark SL, Cotton DB, Hankins GDV, Phelan JP, editors. Critical Care Obstetrics, 2nd edn. Oxford: Blackwell Scientific Publications; 1991. pp. 256.
7. Mundle S, Regi A, Easterling T, Biswas B, Bracken H, Khedekar V, et al. Treatment approaches for preeclampsia in low-resource settings: a randomized trial of the Springfusor pump for delivery of magnesium sulfate. Pregnancy Hypertens 2012; 2: 32-8.
8. Kataria BK, Ved SA, Nicodemus HF, Hoy GR, Lea D, Dubois MY, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 1994; 80: 104-22.
9. Shafer SL, Varvel JR, Aziz N, Scott JC,. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990; 73: 1091-102.
10. Chuan FS, Charles BG, Boyle RK, Rasiah RL,. Population pharmacokinetics of magnesium in preeclampsia. Am J Obstet Gynecol 2001; 185: 593-9.
11. Lu J, Pfister M, Ferrari P, Chen G, Sheiner L,. Pharmacokinetic- pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clin Pharmacokinet 2002; 41: 1105-13.
12. Beal S, Sheiner LB, Boeckmann A, Bauer RJ,. NONMEM User's Guides. Ellicott City, MD: Icon Development Solutions, 2009.
13. Wählby U, Jonsson EN, Karlsson MO,. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 2001; 28: 231-52.
14. Sibai BM, Graham JM, McCubbin JH,. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984; 150: 728-33.
15. Hankins GD, Snyder RR, Hauth JC, Gilstrap LC, Wians FH, van Dellen AF,. Magnesium sulfate pharmacokinetics: pregnant Capra hircus model. Am J Perinatol 1990; 7: 49-53.
16. Begum R, Begum A, Johanson R, Ali MN, Akhter S,. A low dose ("Dhaka") magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand 2001; 80: 998-1002.